Information services

Information services

Adaptimmune Therapeutics Announces FDA Acceptance of IND for MAGE-A10 T Therapeutic Candidate in Non-Small Cell Lung Cancer

Adaptimmune Therapeutics, a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products, has announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors (TCRs) specific for MAGE A10

Information services

Thomson Reuters Enhances Electronic Trading Platform with FXall Liquidity Integration

Thomson Reuters, a leading provider of intelligent information for businesses and professionals, has announced significant enhancements to its Electronic Trading platform, integrating liquidity from FXall and improving customer experience. The new enhancements aim to enrich liquidity, reduce latency, and offer more competitive prices to customers while optimizing risk management. Key